List of insiders holdings for Horizon Therapeutics Public Ltd Co:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| ESSEX WOODLANDS HEALTH VENTURES FUND VII LP 10% Owner | 2012-03-05 17:35:41 | 5,755,100 0 | 5,755,100 | Form 4 |
| Johann Peter Director | 2011-08-04 17:15:36 | 0 4,590,751 | 4,590,751 | Form 4 |
| VENKATARAMAN BALAJI Former 10% Owner | 2015-03-04 16:00:59 | 4,586,317 0 | 4,586,317 | Form 13D |
| FORMELA JEAN FRANCOIS Director 10% Owner | 2012-03-06 15:28:38 | 0 3,895,404 | 3,895,404 | Form 4 |
| Quaker BioVentures II LP 10% Owner | 2014-08-07 09:00:16 | 3,547,457 0 | 3,547,457 | Form 13G |
| ATLAS VENTURE FUND VI LP Atlas Venture Associates VI Inc ATLAS VENTURE ENTREPRENEURS FUND VI LP Atlas Venture Fund VI GmbH & Co KG 10% Owner | 2015-02-12 14:13:42 | 3,386,898 0 | 3,386,898 | Form 13G |
| ATLAS VENTURE FUND VI LP Atlas Venture Fund VI GmbH & Co KG Atlas Venture Associates VI L.P. ATLAS VENTURE ENTREPRENEURS FUND VI LP 10% Owner | 2015-02-12 14:13:42 | 3,386,898 0 | 3,386,898 | Form 13G |
| BOCK LOUIS C Director | 2011-08-04 17:35:14 | 0 2,266,631 | 2,266,631 | Form 4 |
| Scale Venture Partners II LP Scale Venture Management II LLC MITCHELL KATE O'Driscoll Rory Wienbar Sharon L 10% Owner | 2011-08-12 13:19:44 | 2,266,631 0 | 2,266,631 | Form 13D |
| NGN BIOMED OPPORTUNITY I GMBH & CO. BETEILIGUNGS KG NGN BioMed Opportunity I L P 10% Owner | 2011-07-28 17:33:25 | 2,107,422 0 | 2,107,422 | Form 3 |
| Birner Hubert Director | 2011-08-04 17:14:32 | 0 1,672,158 | 1,672,158 | Form 4 |
| Carey Robert EVP, Chief Business Officer | 2019-03-25 21:12:52 | 17,267 249,091 | 266,358 | Form 4 |
| Nohria Virinder Director | 2017-05-10 19:21:46 | 189,836 19,211 | 209,047 | Form 4/A |
| Kelly David George EVP, Company Secretary | 2016-03-24 18:52:15 | 183,638 19,250 | 202,888 | Form 4 |
| MOZE BARRY EVP, Chief Admin. Officer | 2022-01-06 20:58:01 | 182,954 0 | 182,954 | Form 4 |
| BIRD JEFFREY W Director | 2014-03-13 16:35:57 | 0 178,406 | 178,406 | Form 4/A |
| Hoelscher Paul W. EVP, CFO | 2022-04-22 18:47:19 | 37,473 139,462 | 176,935 | Form 4 |
| DE VAERE ROBERT J EVP & CFO | 2014-10-02 17:58:47 | 154,514 0 | 154,514 | Form 4 |
| Kent Jeff See remarks | 2021-05-12 17:02:34 | 126,994 0 | 126,994 | Form 4 |
| Lin Shao-Lee EVP, Head of R&D and CSO | 2020-01-23 16:22:44 | 121,930 0 | 121,930 | Form 4 |
| Karnani Vikram EVP & President, International | 2021-02-23 18:20:36 | 104,165 0 | 104,165 | Form 4 |
| SMITH TODD N EVP & Chief Commercial Officer | 2015-02-04 12:43:42 | 95,961 0 | 95,961 | Form 4/A |
| Konstantinovsky Irina EVP, Chief Human Resources Off | 2021-02-23 18:19:57 | 81,677 0 | 81,677 | Form 4 |
| Kody John J EVP, Chief Commercial Officer | 2015-11-25 13:00:06 | 69,691 0 | 69,691 | Form 4 |
| McHugh Miles W Sr VP & Princ. Acctg Officer | 2022-01-06 21:02:57 | 67,044 0 | 67,044 | Form 4 |
| ADATTO MICHAEL SVP, Managed Care & Comm. Dev. | 2013-01-03 14:37:53 | 64,461 0 | 64,461 | Form 4 |
| Beeler Brian K EVP, General Counsel | 2021-09-17 17:06:11 | 62,775 0 | 62,775 | Form 4 |
| Camardo Daniel A. EVP and President, U.S. | 2021-04-05 17:25:18 | 58,955 0 | 58,955 | Form 4 |
| CURTIS GEOFFREY M. EVP, Corporate Affairs, CCO | 2021-04-02 17:13:34 | 52,675 420 | 53,095 | Form 4 |
| HAMPTON GEORGE P EVP, Primary Care Bus. Unit | 2018-04-02 16:24:07 | 48,473 0 | 48,473 | Form 4 |
| LEONARDI JACOPO Pres., Global Commercial Ops | 2022-06-03 18:07:38 | 44,466 0 | 44,466 | Form 4 |
| ACKERMAN TIMOTHY J. SVP, Commercial Operations | 2017-01-11 16:29:25 | 41,129 0 | 41,129 | Form 4 |
| Thomas John B EVP, Corporate Strategy and IR | 2016-05-10 16:43:50 | 35,745 0 | 35,745 | Form 4 |
| Pauli Ronald Director | 2019-05-06 17:44:38 | 0 33,600 | 33,600 | Form 4 |
| Happel David EVP, Commercial Dev & Strategy | 2017-10-26 19:39:36 | 28,949 0 | 28,949 | Form 4 |
| Rosen Karin EVP, R&D & CSO | 2021-01-06 21:15:14 | 24,449 0 | 24,449 | Form 4 |
| Mosbrooker Eric SVP, Orphan Business Unit | 2017-11-02 16:13:24 | 16,891 0 | 16,891 | Form 4 |
| McIlvenny Patrick Chief Accounting Officer | 2023-10-06 18:08:43 | 0 0 | 0 | Form 4 |
| Watkins Thomas Director | 2023-10-06 18:24:28 | 0 0 | 0 | Form 4 |
| Mahony Susan Director | 2023-10-06 18:22:58 | 0 0 | 0 | Form 4 |
| Witz Pascale Director | 2023-10-06 18:21:24 | 0 0 | 0 | Form 4 |
| GREY MICHAEL G Director | 2023-10-06 18:19:58 | 0 0 | 0 | Form 4 |
| Daniel William F Director | 2023-10-06 18:17:47 | 0 0 | 0 | Form 4 |
| Himawan Jeff Director | 2023-10-06 18:15:32 | 0 0 | 0 | Form 4 |
| Shannon James Samuel Director | 2023-10-06 18:13:09 | 0 0 | 0 | Form 4 |
| SANTINI GINO Director | 2023-10-06 18:10:03 | 0 0 | 0 | Form 4 |
| Pasternak Andy EVP, Chief Strategy Officer | 2023-10-06 18:03:58 | 0 0 | 0 | Form 4 |
| Thompson Elizabeth H.Z. EVP, Research & Development | 2023-10-06 18:01:21 | 0 0 | 0 | Form 4 |
| Cox Aaron EVP, Chief Financial Officer | 2023-10-06 17:59:28 | 0 0 | 0 | Form 4 |
| Walbert Timothy P Chairman, President and CEO | 2023-10-06 17:57:24 | 0 0 | 0 | Form 4 |
| DesJardin Michael A. EVP, Technical Operations | 2023-10-06 17:54:12 | 0 0 | 0 | Form 4 |
| Clayton Sean M. EVP, General Counsel | 2023-10-06 17:51:42 | 0 0 | 0 | Form 4 |
| SHERMAN JEFFREY W EVP and Chief Medical Officer | 2023-10-06 17:48:49 | 0 0 | 0 | Form 4 |
| Vidara Therapeutics Holdings LLC Former 10% Owner 10% Owner | 2014-09-23 17:04:00 | 0 0 | 0 | Form 13D |